These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8414090)

  • 1. [Plasmapheresis and high-dose immunoglobulins in the treatment of acute demyelinating polyneuropathy].
    Marino A; Logi G; Roncucci P; Sodini ML; Fornaini F
    Minerva Anestesiol; 1993 Jun; 59(6):307-11. PubMed ID: 8414090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
    Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
    Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome].
    Hidou M; Olivier J; Vivant JF
    Rev Neurol (Paris); 1992; 148(11):706-8. PubMed ID: 1303562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulins i.v.: a new approach to the treatment of Guillain-Barré syndrome.
    Fasanaro AM; Pizza V; Rossi V
    Minerva Med; 1996; 87(1-2):17-20. PubMed ID: 8610020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution and treatment of childhood chronic inflammatory polyneuropathy.
    Rossignol E; D'Anjou G; Lapointe N; Haddad E; Vanasse M
    Pediatr Neurol; 2007 Feb; 36(2):88-94. PubMed ID: 17275659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of Guillain-Barré syndrome].
    Zagar M
    Lijec Vjesn; 1995; 117(9-10):246-9. PubMed ID: 8643018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guillain-Barré syndrome in childhood. Characteristic course and therapeutic possibilities].
    Korinthenberg R; Sauer M
    Monatsschr Kinderheilkd; 1992 Nov; 140(11):792-8. PubMed ID: 1335122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical course and treatment of acute inflammatory demyelinating polyradiculoneuropathy (Landry-Guillain-Barré syndrome)].
    Mozolevskiĭ IuV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):6-9. PubMed ID: 1326178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasmapheresis and hormone therapy in severe forms of Guillain-Barré syndrome].
    Levchenko NI; Piradov MA; Pirogov VN
    Klin Med (Mosk); 1989 Dec; 67(12):88-91. PubMed ID: 2560799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M; Nevo Y
    Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.
    Neurology; 1985 Aug; 35(8):1096-104. PubMed ID: 4022342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic inflammatory demyelinating polyneuropathy (CIDP)].
    Tanaka H; Baba M
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):479-82. PubMed ID: 10434704
    [No Abstract]   [Full Text] [Related]  

  • 14. [Steroid therapy and plasmapheresis in chronic inflammatory demyelinating polyradiculoneuropathy: a long-term follow-up study].
    Hanaoka N; Hanyu N; Yanagisawa N
    Rinsho Shinkeigaku; 1998 Mar; 38(3):208-12. PubMed ID: 9711115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoglobulins in the therapy of the Guillain-Barré syndrome in childhood].
    Koelfen W; Rohr H
    Dtsch Med Wochenschr; 1994 Oct; 119(42):1449-50. PubMed ID: 7956764
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute Guillain-Barré-like polyradiculoneuritis revealing acute systemic lupus erythematosus: two case studies and review of the literature].
    Aït Benhaddou E; Birouk N; El Alaoui-Faris M; Mzalek-Tazi Z; Aïdi S; Belaïdi H; Kably B; Ouazzani R; Chkili T
    Rev Neurol (Paris); 2003 Mar; 159(3):300-6. PubMed ID: 12703046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and neurophysiologic study of Guillain Barré syndrome: results of therapy with plasmapheresis].
    Fasanaro AM; Pizza V; Florio C; Tancredi G; Fabbri P; Aiello L; Viscidi E; Rossi V; Vacca C
    Riv Neurol; 1991; 61(1):39-45. PubMed ID: 1857922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of plasmapheresis and other immunomodulating therapies on the course of severe Guillain-Barré syndrome].
    Hidasi E; Soltész P
    Orv Hetil; 2001 Feb; 142(7):335-9. PubMed ID: 11243015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasmapheresis in 2 children with Guillain-Barré syndrome].
    Rotteveel JJ; Mullaart RA; Weemaes CM; van Empelen R
    Tijdschr Kindergeneeskd; 1983 Apr; 51(2):57-62. PubMed ID: 6879585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain Barre syndrome-electrodiagnostic features and therapeutic observations.
    Shankar V; Bhanu K; Sayeed ZA
    J Assoc Physicians India; 1995 Oct; 43(10):670-2. PubMed ID: 8773000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.